Involvement of the dopaminergic system has been suggested in patients suffering from ADHD since the symptoms can be successfully treated with MPH, a potent blocker of the dopamine transporter (DAT) [24]. The gene discussed is SLC6A3; the disease is attention deficit-hyperactivity disorder.